TEM•benzinga•
Cathie Wood-Backed Tempus AI Says Pharma Contracts Solid Despite Biotech Funding Challenges, Tariff Pressures
Summary
Tempus AI reassured investors that its major pharma contracts remain strong despite funding and tariff pressures.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 7, 2025 by benzinga